8q24 allelic imbalance and MYC gene copy number in primary prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 13, Issue 3, 2010, Pages 238-243

  Chen, H ^a   Liu, W ^a   Roberts, W ^b   Hooker, S ^a   Fedor, H ^b   DeMarzo, A ^b   Isaacs, W ^b   Kittles, R A ^a,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

8q24; Allelic imbalance; DNA copy number; MYC gene

Indexed keywords

DNA; MYC PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CHROMOSOME 8Q; CLINICAL ARTICLE; CONTROLLED STUDY; GENE DOSAGE; GENE LOCUS; GENE MUTATION; GLEASON SCORE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MALE; ONCOGENE MYC; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ALLELIC IMBALANCE; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 8; DNA PRIMERS; GENE DOSAGE; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS;

EID: 77955712714     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2010.20     Document Type: Article

References (27)

1. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006; 38: 652-658.
2. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007; 39: 631-637.
3. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39: 645-649.
4. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 2007; 39: 638-644.
5. Witte JS. Multiple prostate cancer risk variants on 8q24. Nat Genet 2007; 39: 579-580.
6. Robbins C, Torres JB, Hooker S, Bonilla C, Hernandez W, Candreva A et al. Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Res 2007; 17: 1717-1722.
7. Wang L, McDonnell SK, Slusser JP, Hebbring SJ, Cunningham JM, Jacobsen SJ et al. Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res 2007; 67: 2944-2950.
8. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med 2008; 358: 910-919.
9. Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE et al. Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 2008; 100: 962-966.
10. Tomlinson I,Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 2007; 39: 984-988.
11. Zanke BW, Greenwood CM, Rangrej J, Kustra R, Tenesa A, Farrington SM et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 2007; 39: 989-994.
12. Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KK, Stacey SN et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 2008; 40: 1307-1312.
13. Kupfer SS, Torres JB, Hooker S, Anderson JR, Skol AD, Ellis NA et al. Novel single nucleotide polymorphism associations with colorectal cancer on chromosome 8q24 in African and European Americans. Carcinogenesis 2009; 30: 1353-1357.
14. Tuupanen S, Niittymaki I, Nousiainen K, Vanharanta S, Mecklin JP, Nuorva K et al. Allelic imbalance at rs6983267 suggests selection of the risk allele in somatic colorectal tumor evolution. Cancer Res 2008; 68: 14-17.
15. Qian J, Jenkins RB, Bostwick DG. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization. Mod Pathol 1997; 10: 1113-1119. (Pubitemid 27521289)
16. Jenkins RB, Qian J, Lieber MM, Bostwick DG. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res 1997; 57: 524-531.
17. Liu W, Xie CC, Zhu Y, Li T, Sun J, Cheng Y et al. Homozygous deletions and recurrent amplifications implicate new genes involved in prostate cancer. Neoplasia 2008; 10: 897-907.
18. Lapointe J, Li C, Giacomini CP, Salari K, Huang S, Wang P et al. Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. Cancer Res 2007; 67: 8504-8510.
19. Ribeiro FR, Henrique R, Martins AT, Jeronimo C, Teixeira MR. Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients. Eur Urol 2007; 52: 116-125.
20. Gurel B, Iwata T, Koh CM, Jenkins RB, Lan F, Van Dang C et al. Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Mod Pathol 2008; 21: 1156-1167.
21. Canzian F, Salovaara R, Hemminki A, Kristo P, Chadwick RB, Aaltonen LA et al. Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res 1996; 56: 3331-3337.
22. Liu W, Wu X, Zhang W, Montenegro RC, Fackenthal DL, Spitz JA et al. Relationship of EGFR mutations, expression, amplification, and polymorphisms to epidermal growth factor receptor inhibitors in the NCI60 cell lines. Clin Cancer Res 2007; 13: 6788-6795.
23. Moroni M, Veronese S, Benvenuti S, Marrapese G, Sartore- Bianchi A, Di Nicolantonio F et al. Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. Lancet Oncol 2005; 6: 279-286.
24. Potts PR, Yu H. Human MMS21/NSE2 is a SUMO ligase required for DNA repair. Mol Cell Biol 2005; 25: 7021-7032.
25. Wirtenberger M, Hemminki K, Forsti A, Klaes R, Schmutzler RK, Grzybowska E et al. c-MYC Asn11Ser is associated with increased risk for familial breast cancer. Int J Cancer 2005; 117: 638-642. (Pubitemid 41504552)
26. Tuupanen S, Turunen M, Lehtonen R, Hallikas O, Vanharanta S, Kivioja Tet al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet 2009; 41: 885-890.
27. Kilpivaara O, Mukherjee S, Schram AM, Wadleigh M, Mullally A, Ebert BL et al. A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms. Nat Genet 2009; 41: 455-459.